Saudi: Tabuk partners with Levolta to commercialise OA therapy

Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation and will be responsible for registering, importing, and commercialising VOLT01 in the MEA region

Related Keywords

United States ,Tabuk ,Saudi Arabia ,Wisam Alkhatib ,Richardp Becker Jr ,Mohammed Al Hagbani ,Ketan Desai ,Astra Industrial Group ,Syndigate Media Inc ,Tabuk Pharmaceuticals ,Us Levolta Pharmaceuticals ,Business Development ,Tabuk Pharmaceutical Manufacturing Company ,Marketing Group ,Tabuk Pharmaceuticals Vice ,Levolta Pharmaceuticals ,Middle East ,Levolta Chief Executive Officer ,Richardp Becker ,Levolta Chief Medical Officer ,Tabuk Pharmaceuticals Vice President ,Hilal Publishing ,Marketing Group Provided ,Syndigate Media ,